サマリー

がん情報システムは、患者さんごとに異なる治療スケジュール、治療計画、治療実施などのデータを管理するシステムです。OISの標準化に注力することで、集学的アプローチによる各がん患者のケアレベルの向上がさらに進んでいます。医療費の増加やがん患者の増加を抑制するためにOISソリューションの導入が進んでいるなどの要因から、予測期間中に大きな成長が見込まれます。例えば、米国国立がん研究所によると、2040年までに新たながん患者数は2950万人、がん関連死亡者数は年間1640万人に増加すると予想されています。さらに、幅広い新技術の開発が、予測期間中に腫瘍情報システム市場に大きな機会をもたらすと考えられます。
"予測期間中、ソフトウェアセグメントが最大のシェアを占めた"

2021年の製品・サービス別がん情報システム市場において、ソフトウェア分野は83.6％を占めています。ソフトウェアは、システムの実行や、あらゆる医療機関や病院における患者記録の維持や治療計画の実行などの主要タスクの実行に使用される非有形のコンポーネントである。HCIT市場の不可欠な要素であり、データベースとエンドユーザーとの間のインターフェースとして機能します。医療機関はオンプレミス型からウェブベースやクラウドベース型に移行しており、予測期間中のこの分野の成長を後押ししています。

"予測期間中、放射線腫瘍学セグメントが最大のシェアを占めた。"
2021年、放射線腫瘍学セグメントは、アプリケーション向け腫瘍学情報システム市場の53.8%を占めた。放射線腫瘍学は、放射線によるがん治療を専門としており、腫瘍に直接高線量を照射し、腫瘍周辺の健康な組織への被ばくを最小限に抑えてがん細胞を死滅させます。これにより、合併症や副作用、健康な組織への二次的影響が制限されるため、放射線腫瘍学の進歩が促進されています。放射線腫瘍学の新しい治療法として、外部照射療法（EBRT）、内部照射療法（IBRT）、術中照射療法（IORT）、小線源療法などが広く用いられている。放射線治療システムとOISの統合により、臨床医は放射線量計算を高速化し、全体的な治療計画を効率化することができます。

"予測期間中、病院と画像診断センターセグメントが最大のシェアを占めた。"

2021年、病院と画像診断センターは、腫瘍情報システム市場の64.5％を占めた。病院が腫瘍情報システムの最大のエンドユーザーであるのは、世界中で毎年かなりの数の患者提出/受診があること、病院に新しい高度なシステムを装備（またはアップグレード）することを目的とした政府のイニシアティブが増加していること、がん治療の施術数が増加していること、腫瘍治療ケアの導入が進んでいることなどが理由であると考えられます。さまざまな種類の癌の負担の増加、世界的に実施されている診断手順の増加などが、腫瘍情報システム市場における診断用画像処理センターの成長を促す要因となっています。

"予測期間中、アジア太平洋地域が最も高いCAGRで成長すると予測される。"
2021年、アジア太平洋地域は世界の腫瘍情報システム市場の17.8％を占めています。APAC市場の成長は、医療ITインフラの進歩のための投資の増加や、医療現場における医療ITソリューションの導入に対する政府支援の増加など、いくつかの要因によってもたらされています。GLOBOCANによると、2020年、日本では新たに83万395人のがん患者が発生したと記録されています。WHOは、2040年までに日本のがん罹患数が997,537人に増加する可能性があると予測しています。日本では、健康情報ビッグデータを活用するための電子カルテの導入が大きな課題となっています。日本政府によると、2019年の病院における電子カルテとオーダリングシステムの導入率は、それぞれ34.4％と43.6％となっています。

腫瘍情報システム市場で事業を展開する様々な主要組織の最高経営責任者（CEO）、マーケティングディレクター、その他のイノベーションおよびテクノロジーディレクター、経営幹部に対して詳細なインタビューを実施した。
企業タイプ別ティア1：46％、ティア2：33％、ティア3：21
役職別Cレベルエグゼクティブ43%, 取締役:役職別：C-level Executive: 43%, Director: 35%, Others: 22
地域別では北米：30％、欧州：35％、APAC：24％、中南米：14％、中東・アフリカ：4

がん情報システム市場における主なプレイヤーは、Koninklijke Philips N.V.（オランダ）、McKesson Corporation（米国）、Siemens Healthineers（ドイツ）、Elekta AB（スウェーデン）、Epic Systems Corporation（米国）、IBM（米国）、Cerner Corporation（米国）、Advanced Data Systems（米国）、Bogardus Medical Systems, Inc（米国）、F. Hoffmann-La Roche AG（スイス）、Altai Oncology, LLC.(米国）、GEヘルスケア（米国）、Accuray Incorporated（米国）、OPTUM（UnitedHealth Groupの一部）（米国）、Allscripts Healthcare Solutions, Inc（米国）、MICA Information Systems, Inc（米国）、CureMD Healthcare（米国）、EndoSoft LLC（米国）、MIM Software Inc（米国）およびRaySearch Laboratories AB（スウェーデン）である。
調査対象範囲
本レポートでは、世界の腫瘍情報システム市場を製品・サービス、アプリケーション、エンドユーザー、地域レベルに基づいて説明・調査しています。この市場の成長に影響を与える主要な要因に関する詳細な情報を提供しています。また、本市場の有力企業の詳細な競合分析および製品マトリックス、企業プロファイル、製品ポートフォリオ、最近の開発、MNMの概要などを掲載しています。
レポート購入の主なメリット
本レポートは、本市場の市場リーダー/新規参入者に役立ち、腫瘍情報システム市場全体とそのサブセグメントにおける収益数の最も近い近似値に関する情報を提供します。本レポートは、利害関係者が競争状況を理解し、自社のビジネスをより良く位置づけるためのより多くの洞察を得て、適切な市場参入戦略を計画するために役立ちます。また、利害関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供するのにも役立ちます。
本レポートでは、以下に関する洞察を提供します。
市場浸透度。腫瘍情報システム市場におけるトッププレイヤーの製品ポートフォリオに関する包括的な情報。製品・サービス、アプリケーション、エンドユーザー、地域別に本市場を分析しています。
市場の発展。製品・サービス、アプリケーション、エンドユーザー、地域別に、有利な新興市場に関する包括的な情報を提供します。
市場の多様化。腫瘍情報システム市場における製品ポートフォリオ、成長地域、最近の開発、投資に関する徹底的な情報を提供します。
競合の評価。腫瘍情報システム市場における主要企業の市場シェア、成長戦略、製品提供、能力に関する詳細な評価。

ページTOPに戻る

目次

1 INTRODUCTION 38
1.1 OBJECTIVES OF THE STUDY 38
1.2 MARKET DEFINITION 38
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 39
1.3 MARKET SCOPE 39
1.3.1 MARKETS COVERED 40
FIGURE 1 ONCOLOGY INFORMATION SYSTEMS MARKET SEGMENTATION 40
1.3.2 YEARS CONSIDERED FOR THE STUDY 41
1.4 CURRENCY 41
TABLE 1 STANDARD CURRENCY CONVERSION RATES 41
1.5 LIMITATIONS 42
1.6 STAKEHOLDERS 42
1.7 SUMMARY OF CHANGES 42
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH APPROACH 44
FIGURE 2 RESEARCH DESIGN 44
2.1.1 SECONDARY DATA 45
2.1.1.1 Key data from secondary sources 45
2.1.2 SECONDARY RESEARCH 46
2.1.3 PRIMARY RESEARCH 47
FIGURE 3 PRIMARY SOURCES 47
2.1.3.1 Key data from primary sources 48
FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS 48
2.1.3.2 Breakdown of primary sources 49
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 49
FIGURE 6 PRIMARY SOURCES 49
2.2 MARKET SIZE ESTIMATION 50
2.2.1 BOTTOM-UP APPROACH 50
FIGURE 7 ONCOLOGY INFORMATION SYSTEMS MARKET: BOTTOM-UP APPROACH 51
2.2.2 TOP-DOWN APPROACH 51
FIGURE 8 ONCOLOGY INFORMATION SYSTEMS MARKET: TOP-DOWN APPROACH 51
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 52
FIGURE 10 ONCOLOGY INFORMATION SYSTEMS MARKET (2021): SUPPLY-SIDE MARKET SIZE ESTIMATION 53
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 54
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ONCOLOGY INFORMATION SYSTEMS MARKET (2022–2027) 54
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 56
FIGURE 13 DATA TRIANGULATION METHODOLOGY 56
2.4 MARKET SHARE ESTIMATION 56
2.5 ASSUMPTIONS FOR THE STUDY 57
2.6 RISK ASSESSMENT 57
TABLE 2 RISK ASSESSMENT: ONCOLOGY INFORMATION SYSTEMS MARKET 57
3 EXECUTIVE SUMMARY 58
FIGURE 14 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION) 58
FIGURE 15 ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 59
FIGURE 16 PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 60
FIGURE 17 TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 61
FIGURE 18 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 62
FIGURE 19 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 63
FIGURE 20 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 64
FIGURE 21 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 65
FIGURE 22 GEOGRAPHICAL SNAPSHOT OF THE ONCOLOGY INFORMATION SYSTEMS MARKET 66
4 PREMIUM INSIGHTS 68
4.1 ONCOLOGY INFORMATION SYSTEMS MARKET OVERVIEW 68
FIGURE 23 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH 68
4.2 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE (2022–2027) 69
FIGURE 24 CONSULTING & OPTIMIZATION SERVICES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 69
4.3 APAC: ONCOLOGY INFORMATION SYSTEMS MARKET SHARE,
BY APPLICATION AND COUNTRY (2021) 70
FIGURE 25 RADIATION ONCOLOGY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 70
4.4 ONCOLOGY INFORMATION SYSTEMS MARKET: DEVELOPED VS. DEVELOPING MARKETS (USD MILLION) 71
FIGURE 26 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 71
4.5 ONCOLOGY INFORMATION SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 72
FIGURE 27 CHINA TO WITNESS HIGHEST GROWTH FROM 2022 TO 2027 72
 
5 MARKET OVERVIEW 73
5.1 INTRODUCTION 73
5.2 MARKET DYNAMICS 73
FIGURE 28 ONCOLOGY INFORMATION SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 73
5.2.1 DRIVERS 74
5.2.1.1 Need to curtail oncology care costs 74
FIGURE 29 GLOBAL ONCOLOGY SPENDING, 2015–2021 (USD BILLION) 74
5.2.1.2 Growing adoption of EHRs and other oncology healthcare IT solutions to improve care quality 75
FIGURE 30 PERCENTAGE OF PRIMARY CARE PHYSICIANS IN SELECTED COUNTRIES USING ELECTRONIC MEDICAL RECORDS (2019) 75
5.2.1.3 Increasing incidence and prevalence of cancer 76
TABLE 3 CANCER INCIDENCE PER MILLION POPULATION, BY COUNTRY, 2016–2020 76
5.2.1.4 Favorable government mandates and support for oncology information systems 77
5.2.1.5 Potential benefits of and technological advancements in oncology information systems 78
5.2.2 RESTRAINTS 79
5.2.2.1 Interoperability issues 79
5.2.2.2 Dearth of skilled IT professionals in healthcare industry 80
5.2.3 OPPORTUNITIES 81
5.2.3.1 Growing healthcare IT Industry 81
5.2.3.2 Integration of EMR with treatment planning systems 81
5.2.4 CHALLENGES 82
5.2.4.1 Concerns regarding data privacy 82
6 INDUSTRY INSIGHTS 83
6.1 INTRODUCTION 83
6.2 TECHNOLOGY ANALYSIS: ONCOLOGY INFORMATION SYSTEMS 83
6.2.1 ARTIFICIAL INTELLIGENCE 83
6.2.2 MACHINE LEARNING 83
6.2.3 INTERNET OF THINGS 83
6.2.4 BLOCKCHAIN 84
6.3 PRICING ANALYSIS: ONCOLOGY INFORMATION SYSTEMS 84
6.4 ECOSYSTEM LANDSCAPE: ONCOLOGY INFORMATION SYSTEMS MARKET 84
FIGURE 31 ONCOLOGY INFORMATION SYSTEMS MARKET: ECOSYSTEM 85
6.5 REGULATORY ANALYSIS 86
6.5.1 NORTH AMERICA 86
6.5.2 EUROPE 87
6.5.3 ASIA PACIFIC 87
6.5.4 MIDDLE EAST & AFRICA 88
6.5.5 LATIN AMERICA 88
6.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 7 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 8 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
6.7 PORTER’S FIVE FORCES ANALYSIS 91
FIGURE 32 DEGREE OF COMPETITION IS HIGH IN THE ONCOLOGY INFORMATION SYSTEMS MARKET 91
TABLE 9 ONCOLOGY INFORMATION SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS 92
6.7.1 THREAT OF NEW ENTRANTS 92
6.7.2 THREAT OF SUBSTITUTES 93
6.7.3 BARGAINING POWER OF SUPPLIERS 93
6.7.4 BARGAINING POWER OF BUYERS 93
6.7.5 INTENSITY OF COMPETITIVE RIVALRY 93
6.8 KEY STAKEHOLDERS & BUYING CRITERIA 94
6.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 94
FIGURE 33 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR ONCOLOGY INFORMATION SYSTEMS 94
TABLE 10 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS 94
6.9 KEY BUYING CRITERIA BY END USERS 95
FIGURE 34 BUYING CRITERIA OF END USERS 95
TABLE 11 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 95
6.10 PATENT ANALYSIS 96
6.10.1 PATENT PUBLICATION TRENDS FOR ONCOLOGY INFORMATION SYSTEMS 96
FIGURE 35 GLOBAL PATENT PUBLICATION TRENDS IN ONCOLOGY INFORMATION SYSTEMS MARKET, 2018–2022 96
6.10.2 TOP APPLICANTS (COMPANIES) FOR ONCOLOGY INFORMATION SYSTEM PATENTS 97
FIGURE 36 TOP COMPANIES THAT APPLIED FOR ONCOLOGY INFORMATION SYSTEM PATENTS, 2018–2022 97
6.11 KEY CONFERENCES & EVENTS IN 2022-2023 97
TABLE 12 ONCOLOGY INFORMATION SYSTEMS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 97
6.12 COVID-19 IMPACT ON ONCOLOGY INFORMATION SYSTEMS MARKET 99
 
7 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE 100
7.1 INTRODUCTION 101
TABLE 13 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 101
7.2 SOFTWARE 101
TABLE 14 ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 102
TABLE 15 ONCOLOGY INFORMATION SOFTWARE MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 103
7.2.1 PATIENT INFORMATION SYSTEMS 103
TABLE 16 PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 104
TABLE 17 PATIENT INFORMATION SYSTEMS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 105
7.2.1.1 Oncology electronic medical records 105
7.2.1.1.1 Adoption of oncology electronic medical records is growing significantly in emerging countries 105
TABLE 18 KEY PLAYERS OFFERING ONCOLOGY ELECTRONIC MEDICAL RECORDS 106
TABLE 19 ONCOLOGY ELECTRONIC MEDICAL RECORDS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 107
7.2.1.2 Laboratory information systems 107
7.2.1.2.1 Need for accurate, efficient, and rapid transfer of lab results across networks to drive market growth 107
TABLE 20 KEY PLAYERS OFFERING LABORATORY INFORMATION SYSTEMS 108
TABLE 21 LABORATORY INFORMATION SYSTEMS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 108
7.2.1.3 Radiology information systems 109
7.2.1.3.1 Integration of RIS with HIS and PACS has attracted attention from stakeholders 109
TABLE 22 KEY PLAYERS OFFERING RADIOLOGY INFORMATION SYSTEMS 109
TABLE 23 RADIOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 110
7.2.1.4 Chemotherapy information systems 110
7.2.1.4.1 Chemotherapy is increasingly being adopted as primary mode of treatment for various cancer types 110
TABLE 24 KEY PLAYERS OFFERING CHEMOTHERAPY INFORMATION SYSTEMS 111
TABLE 25 CHEMOTHERAPY INFORMATION SYSTEMS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 111
7.2.2 TREATMENT PLANNING SYSTEMS 112
TABLE 26 TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 112
TABLE 27 TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 113
7.2.2.1 Radiotherapy treatment planning systems 113
7.2.2.1.1 Radiotherapy treatment planning systems to witness increased adoption for treatment of deep-seated tumors 113
TABLE 28 KEY MARKET PLAYERS OFFERING RADIOTHERAPY TREATMENT PLANNING SOLUTIONS 114
TABLE 29 RADIOTHERAPY TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 115
7.2.2.2 Clinical decision support systems 115
7.2.2.2.1 Need to minimize errors and ensure regulatory compliance to drive adoption of CDSS 115
TABLE 30 KEY PLAYERS OFFERING CLINICAL DECISION SUPPORT SYSTEMS 116
TABLE 31 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 117
7.2.2.3 Brachytherapy treatment planning systems 117
7.2.2.3.1 Better patient care with pulsed-dose rate brachytherapy to drive demand for these systems 117
TABLE 32 BRACHYTHERAPY TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 118
7.2.3 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS 119
TABLE 33 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 34 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 120
7.2.3.1 Population health management solutions 120
7.2.3.1.1 PHM solutions aggregate and provide wide range of cancer data for providers 120
TABLE 35 KEY PLAYERS OFFERING POPULATION HEALTH MANAGEMENT SOLUTIONS 121
TABLE 36 POPULATION HEALTH MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 122
7.2.3.2 Clinical integration solutions 122
7.2.3.2.1 Increasing number of cancer patient admissions in inpatient facilities is key factor driving market growth 122
TABLE 37 KEY PLAYERS OFFERING CLINICAL INTEGRATION SOLUTIONS 123
TABLE 38 CLINICAL INTEGRATION SOLUTIONS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 124
7.2.3.3 Picture archiving and communication systems & vendor-neutral archive solutions 124
7.2.3.3.1 Rising demand for PACS and increasing generation of image data will ensure sustained demand for these solutions 124
TABLE 39 KEY PLAYERS OFFERING PICTURE ARCHIVING AND COMMUNICATION SYSTEMS & VENDOR-NEUTRAL ARCHIVE SOLUTIONS 126
TABLE 40 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS & VENDOR-NEUTRAL ARCHIVE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 127
7.2.3.4 Advanced visualization & image analysis solutions 127
7.2.3.4.1 Increasing demand for imaging modalities in various indications of oncology to drive segment growth 127
TABLE 41 ADVANCED VISUALIZATION & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 129
7.2.3.5 Radiation dose management solutions 129
7.2.3.5.1 Use of these solutions enables optimization of radiation dose administration and management 129
TABLE 42 KEY PLAYERS OFFERING RADIATION DOSE MANAGEMENT SOLUTIONS 130
TABLE 43 RADIATION DOSE MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 131
7.3 PROFESSIONAL SERVICES 131
TABLE 44 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 45 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 133
7.3.1 IMPLEMENTATION SERVICES 133
7.3.1.1 Healthcare organizations are increasingly outsourcing implementation services 133
TABLE 46 KEY PLAYERS OFFERING IMPLEMENTATION SERVICES 134
TABLE 47 IMPLEMENTATION SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 134
7.3.2 POST-SALE & MAINTENANCE SERVICES 135
7.3.2.1 Rising trend of outsourcing is driving market for post-sale & maintenance services 135
TABLE 48 KEY PLAYERS OFFERING POST-SALE & MAINTENANCE SERVICES 135
TABLE 49 POST-SALE & MAINTENANCE SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 136
7.3.3 CONSULTING & OPTIMIZATION SERVICES 136
7.3.3.1 Consulting services deliver optimum guidance to healthcare providers for implementing oncology information solutions 136
TABLE 50 KEY PLAYERS OFFERING CONSULTING SERVICES 137
TABLE 51 CONSULTING & OPTIMIZATION SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 138
8 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION 139
8.1 INTRODUCTION 140
TABLE 52 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 140
8.2 RADIATION ONCOLOGY 140
8.2.1 INTRODUCTION OF AI-BASED RADIOTHERAPY TREATMENT PLANNING SYSTEMS TO DRIVE MARKET GROWTH 140
TABLE 53 US: RADIATION-TREATED CANCER SURVIVORS, 2016–2030 (THOUSAND) 141
TABLE 54 KEY PRODUCTS IN RADIATION ONCOLOGY MARKET 142
TABLE 55 ONCOLOGY INFORMATION SYSTEMS MARKET FOR RADIATION ONCOLOGY,
BY COUNTRY, 2020–2027 (USD MILLION) 143
8.3 MEDICAL ONCOLOGY 143
8.3.1 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH 143
TABLE 56 KEY PRODUCTS IN MEDICAL ONCOLOGY MARKET 144
FIGURE 37 NUMBER OF ONCOLOGY CLINICAL TRIALS WORLDWIDE, 2012–2018 144
TABLE 57 ONCOLOGY INFORMATION SYSTEMS MARKET FOR MEDICAL ONCOLOGY,
BY COUNTRY, 2020–2027 (USD MILLION) 145
8.4 SURGICAL ONCOLOGY 145
8.4.1 NEED FOR STRUCTURED HEALTHCARE INFORMATION SYSTEMS TO BOOST MARKET GROWTH 145
TABLE 58 KEY PRODUCTS IN SURGICAL ONCOLOGY MARKET 146
TABLE 59 ONCOLOGY INFORMATION SYSTEMS MARKET FOR SURGICAL ONCOLOGY,
BY COUNTRY, 2020–2027 (USD MILLION) 146
9 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER 147
9.1 INTRODUCTION 148
TABLE 60 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER,
2020–2027 (USD MILLION) 148
9.2 HOSPITALS & DIAGNOSTIC IMAGING CENTERS 148
9.2.1 HOSPITALS & DIAGNOSTIC IMAGING CENTERS ARE LARGEST END USERS OF ONCOLOGY INFORMATION SYSTEMS 148
TABLE 61 NUMBER OF HOSPITALS, BY COUNTRY (2021) 149
TABLE 62 ONCOLOGY INFORMATION SYSTEMS MARKET FOR HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 150
9.3 ABLATION & CANCER CARE CENTERS 150
9.3.1 INITIATION OF CANCER CARE PROGRAMS AND SUPPORTING REIMBURSEMENT PLANS TO BOOST SEGMENT GROWTH 150
TABLE 63 ONCOLOGY INFORMATION SYSTEMS MARKET FOR ABLATION & CANCER CARE CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 151
9.4 GOVERNMENT INSTITUTES 152
9.4.1 RISING GOVERNMENT INITIATIVES TO DRIVE MARKET GROWTH 152
TABLE 64 ONCOLOGY INFORMATION SYSTEMS MARKET FOR GOVERNMENT INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 153
9.5 RESEARCH FACILITIES 153
9.5.1 GROWING NUMBER OF CANCER RESEARCH STUDIES TO DRIVE MARKET GROWTH 153
TABLE 65 ONCOLOGY INFORMATION SYSTEMS MARKET FOR RESEARCH FACILITIES,
BY COUNTRY, 2020–2027 (USD MILLION) 154
10 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION 155
10.1 INTRODUCTION 156
FIGURE 38 ONCOLOGY INFORMATION SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 156
TABLE 66 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION,
2020–2027 (USD MILLION) 157
10.2 NORTH AMERICA 157
FIGURE 39 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET SNAPSHOT 158
TABLE 67 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 159
TABLE 68 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 159
TABLE 69 NORTH AMERICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 70 NORTH AMERICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 71 NORTH AMERICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 72 NORTH AMERICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 73 NORTH AMERICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 74 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 75 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY END USER, 2020–2027 (USD MILLION) 163
10.2.1 US 163
10.2.1.1 Rising adoption of oncology information systems in hospitals to drive market growth 163
FIGURE 40 US: HOSPITAL EHR ADOPTION (2010–2018) 164
TABLE 76 US: KEY MACROINDICATORS 165
TABLE 77 US: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 165
TABLE 78 US: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 166
TABLE 79 US: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 166
TABLE 80 US: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 81 US: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 82 US: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
10.2.2 CANADA 168
10.2.2.1 Deployment of digital healthcare initiatives is boosting market growth in Canada 168
FIGURE 41 CANADA: EMR ADOPTION BY PRIMARY CARE PHYSICIANS,
2013–2018 169
TABLE 83 CANADA: KEY MACROINDICATORS 170
TABLE 84 CANADA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 170
TABLE 85 CANADA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 171
TABLE 86 CANADA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 171
TABLE 87 CANADA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 172
TABLE 88 CANADA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 89 CANADA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 173
 
10.3 EUROPE 173
FIGURE 42 EUROPE: CANCER PREVALENCE, BY COUNTRY, 2012–2030 174
TABLE 90 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 175
TABLE 91 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 175
TABLE 92 EUROPE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 176
TABLE 93 EUROPE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 176
TABLE 94 EUROPE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 177
TABLE 95 EUROPE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 96 EUROPE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 97 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 178
TABLE 98 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION) 179
10.3.1 GERMANY 179
10.3.1.1 High adoption of EHR systems among healthcare practitioners to drive market growth in Germany 179
TABLE 99 GERMANY: KEY MACROINDICATORS 180
TABLE 100 GERMANY: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 181
TABLE 101 GERMANY: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 181
TABLE 102 GERMANY: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 182
TABLE 103 GERMANY: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 182
TABLE 104 GERMANY: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 105 GERMANY: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 183
10.3.2 UK 184
10.3.2.1 UK is rapidly transforming its organizations into paperless environments through EHRs 184
TABLE 106 UK: KEY MACROINDICATORS 184
TABLE 107 UK: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 185
TABLE 108 UK: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 185
TABLE 109 UK: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 186
TABLE 110 UK: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 186
TABLE 111 UK: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 112 UK: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 187
10.3.3 FRANCE 188
10.3.3.1 Growing reforms in digital health will support market growth 188
TABLE 113 FRANCE: KEY MACROINDICATORS 188
TABLE 114 FRANCE: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 189
TABLE 115 FRANCE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 189
TABLE 116 FRANCE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 190
TABLE 117 FRANCE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 190
TABLE 118 FRANCE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 119 FRANCE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 191
10.3.4 ITALY 192
10.3.4.1 Increasing government initiatives and reforms to drive market growth 192
TABLE 120 ITALY: KEY MACROINDICATORS 192
TABLE 121 ITALY: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 193
TABLE 122 ITALY: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 193
TABLE 123 ITALY: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 194
TABLE 124 ITALY: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 194
TABLE 125 ITALY: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 126 ITALY: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 195
10.3.5 SPAIN 196
10.3.5.1 Increasing prevalence of cancer to drive adoption of oncology information systems 196
TABLE 127 SPAIN: KEY MACROINDICATORS 196
TABLE 128 SPAIN: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 197
TABLE 129 SPAIN: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 197
TABLE 130 SPAIN: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 198
TABLE 131 SPAIN: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 198
TABLE 132 SPAIN: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 133 SPAIN: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 199
10.3.6 REST OF EUROPE 200
TABLE 134 ROE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 201
TABLE 135 ROE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 201
TABLE 136 ROE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 202
TABLE 137 ROE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 202
TABLE 138 ROE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 203
TABLE 139 ROE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 203
10.4 ASIA PACIFIC 204
FIGURE 43 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET SNAPSHOT 205
TABLE 140 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 206
TABLE 141 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 206
TABLE 142 ASIA PACIFIC: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 143 ASIA PACIFIC: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 207
TABLE 144 ASIA PACIFIC: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 208
TABLE 145 ASIA PACIFIC: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 146 ASIA PACIFIC: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 147 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 209
TABLE 148 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION) 210
10.4.1 JAPAN 210
10.4.1.1 Japan dominates Asia Pacific oncology information systems market 210
TABLE 149 JAPAN: KEY MACROINDICATORS 211
TABLE 150 JAPAN: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 211
TABLE 151 JAPAN: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 212
TABLE 152 JAPAN: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 212
TABLE 153 JAPAN: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 213
TABLE 154 JAPAN: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 155 JAPAN: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 214
10.4.2 CHINA 214
10.4.2.1 Strong government support in China to propel market growth 214
TABLE 156 CHINA: KEY MACROINDICATORS 215
TABLE 157 CHINA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 215
TABLE 158 CHINA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 216
TABLE 159 CHINA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 216
TABLE 160 CHINA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 217
TABLE 161 CHINA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 162 CHINA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 218
10.4.3 INDIA 218
10.4.3.1 Rising need for cost-effective technologies has increased demand for oncology information solutions in India 218
TABLE 163 INDIA: KEY MACROINDICATORS 219
TABLE 164 INDIA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 219
TABLE 165 INDIA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 220
TABLE 166 INDIA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 220
TABLE 167 INDIA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 221
TABLE 168 INDIA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 221
TABLE 169 INDIA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 222
10.4.4 AUSTRALIA 222
10.4.4.1 Supportive government initiatives and strategic developments by market players to drive market growth 222
TABLE 170 AUSTRALIA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 223
TABLE 171 AUSTRALIA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 224
TABLE 172 AUSTRALIA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 224
TABLE 173 AUSTRALIA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 225
TABLE 174 AUSTRALIA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 225
TABLE 175 AUSTRALIA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 226
10.4.5 SOUTH KOREA 226
10.4.5.1 Increasing adoption of oncology information systems to positively impact market growth 226
TABLE 176 SOUTH KOREA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 227
TABLE 177 SOUTH KOREA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 227
TABLE 178 SOUTH KOREA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 228
TABLE 179 SOUTH KOREA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 228
TABLE 180 SOUTH KOREA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 229
TABLE 181 SOUTH KOREA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 229
10.4.6 REST OF ASIA PACIFIC 230
TABLE 182 ROAPAC: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 230
TABLE 183 ROAPAC: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 231
TABLE 184 ROAPAC: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 231
TABLE 185 ROAPAC: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 232
TABLE 186 ROAPAC: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 232
TABLE 187 ROAPAC: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 233
10.5 LATIN AMERICA 233
TABLE 188 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 233
TABLE 189 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 234
TABLE 190 LATIN AMERICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 234
TABLE 191 LATIN AMERICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 235
TABLE 192 LATIN AMERICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 235
TABLE 193 LATIN AMERICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 236
TABLE 194 LATIN AMERICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 236
TABLE 195 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 237
TABLE 196 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY END USER, 2020–2027 (USD MILLION) 237
 
10.5.1 BRAZIL 238
10.5.1.1 Modernization of healthcare infrastructure to drive market growth 238
TABLE 197 BRAZIL: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 238
TABLE 198 BRAZIL: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 239
TABLE 199 BRAZIL: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 239
TABLE 200 BRAZIL: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 240
TABLE 201 BRAZIL: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 240
TABLE 202 BRAZIL: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 241
10.5.2 MEXICO 241
10.5.2.1 Favorable government initiatives and growing medical tourism to drive market growth 241
TABLE 203 MEXICO: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 242
TABLE 204 MEXICO: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 242
TABLE 205 MEXICO: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 243
TABLE 206 MEXICO: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 243
TABLE 207 MEXICO: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 244
TABLE 208 MEXICO: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 244
10.5.3 REST OF LATIN AMERICA 245
TABLE 209 ROLATAM: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 245
TABLE 210 ROLATAM: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020–2027 (USD MILLION) 246
TABLE 211 ROLATAM: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 246
TABLE 212 ROLATAM: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020–2027 (USD MILLION) 247
TABLE 213 ROLATAM: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 247
TABLE 214 ROLATAM: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 248